AIT Therapeutics, Inc. (AITB) financial statements (2020 and earlier)

Company profile

Business Address 825 EAST GATE BOULEVARD, SUITE 320
GARDEN CITY, NY 11530
State of Incorp. DE
Fiscal Year End March 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
3/31/2019
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:9820
Cash and cash equivalents2110
Short-term investments771 
Other undisclosed cash, cash equivalents, and short-term investments00  
Restricted cash and investments000 
Receivables  0 
Prepaid expense0   
Other current assets   0
Other undisclosed current assets010 
Total current assets:10920
Noncurrent Assets
Operating lease, right-of-use asset0
Property, plant and equipment000 
Other undisclosed noncurrent assets00  
Total noncurrent assets:110 
TOTAL ASSETS:11920
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities4310
Accounts payable2110
Accrued liabilities22 0
Deferred revenue1
Debt00 0
Due to related parties000 
Other liabilities   0
Other undisclosed current liabilities 2  
Total current liabilities:5510
Noncurrent Liabilities
Long-term debt and lease obligation0   
Operating lease, liability0
Liabilities, other than long-term debt  9 
Derivative instruments and hedges, liabilities  9 
Total noncurrent liabilities:0 9 
Total liabilities:65110
Stockholders' equity
Stockholders' equity attributable to parent64(8)(0)
Common stock0000
Treasury stock, value(0)(0)(0) 
Additional paid in capital5342230
Accumulated other comprehensive income  0 
Accumulated deficit(48)(38)(32)(0)
Total stockholders' equity:64(8)(0)
TOTAL LIABILITIES AND EQUITY:11920

Income statement (P&L) ($ in millions)

9/30/2019
TTM
3/31/2019
12/31/2017
12/31/2016
Gross profit:98  
Operating expenses(16)(11)(11)(0)
Other undisclosed operating loss(8)   
Operating loss:(15)(3)(11)(0)
Nonoperating expense(2)(3)(0) 
Other nonoperating expense(0)(0)(0) 
Interest and debt expense  (0)(0)
Other undisclosed loss from continuing operations before equity method investments, income taxes  (7) 
Net loss:(18)(7)(18)(0)
Other undisclosed net income (loss) attributable to parent8  (0)
Net loss available to common stockholders, diluted:(9)(7)(18)(0)

Comprehensive Income ($ in millions)

9/30/2019
TTM
3/31/2019
12/31/2017
12/31/2016
Net loss:(18)(7)(18)(0)
Comprehensive loss:(18)(7)(18)(0)
Other undisclosed comprehensive income, net of tax, attributable to parent8 0 
Comprehensive loss, net of tax, attributable to parent:(9)(7)(18)(0)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: